8-Isoprostane, a Marker of Oxidative Stress, Is Increased in Exhaled Breath Condensate of Patients with Obstructive Sleep Apnea after Night and Is Reduced by Continuous Positive Airway Pressure Therapy

Chest

Volumn 124, Issue 4, 2003, Pages 1386-1392

  Carpagnano, Giovanna E ^a   Kharitonov, Sergei A ^b   Resta, Onofrio ^a   Foschino Barbaro, Maria P ^a   Gramiccioni, Enzo ^a   Barnes, Peter J ^b  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

8 isoprostane; Continuous positive airway pressure therapy; Obstructive sleep apnea; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; ISOPROSTANE;

ADULT; AIRWAY PRESSURE; ARTICLE; BLOOD ANALYSIS; BREATHING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; NECK; NIGHT; OXIDATIVE STRESS; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; TIME;

EID: 0142042362     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.124.4.1386     Document Type: Article

References (37)

1. Deegan PC, McNicholas WT. Predictive value of clinical features for the obstructive sleep apnoea syndrome. Eur Respir J 1996; 9:117-124
2. Marrone O, Bonsignore MR, Insalaco G, et al. What is the evidence that obstructive sleep apnoea is an important illness? Monaldi Arch Chest Dis 1998; 53:630-639
3. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. Clin Endocrinol Metab 1997; 82:1313-1316
4. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Am J Respir Crit Care Med 2000; 162:566-570
5. Morrison DL, Launois SH, Isono S, Pharyngeal narrowing and closing pressures in patients with obstructive sleep apnea. Am Rev Respir Dis 1993; 148:606-611
6. Wynne JW. Obstruction of the nose and breathing during sleep. Chest 1982; 26:57-58
7. Rubinstein I, Slutsky AS, Zamel N, et al. Paradoxical glottic narrowing in patients with severe obstructive apnea. J Clin Invest 1988; 81:1051-1055
8. McNicholas WT, Tarlo S, Cole P, et al. Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 1982; 126:625-628
9. Leznoff A, Haight JS, Hoffstein V. Reversible obstructive sleep apnea caused by occupational exposure to guar gum dust. Am Rev Respir Dis 1986; 133:935-936
10. Saul S, Kimmelman CP, LiVolsi VA, et al. Histopathology of sleep apnea. Trans Am Laryngol Assoc 1988; 109:222-225
11. Carpagnano GE, Kharitonov SA, Resta O, et al. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest 2002; 122:1162-1167
12. Kharitonov SA, Barnes PJ. Exhaled markers of inflammation. Curr Opin Allergy Clin Immunol 2001; 1:217-224
13. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163:1693-1722
14. Rechtshaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington, DC: US Government Printing Office, 1986; NIH Publication No. 204
15. Johns MW. Rethinking the assessment of sleepiness. Sleep Med Rev 1998; 2:3-15
16. Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992; 15:376-381
17. Montuschi P, Kharitonov SA, Ciabattoni G, et al. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000; 55:205-209
18. Bland JM, Altman DG. Statistics notes: measurement error. BMJ 1996; 313:744
19. Janssen LJ, Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol 2001; 280:L1067-L1082
20. Montuschi P, Ciabattoni G, Paredi P, et al. 8-isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care 1998; 158:1524-1527
21. Brown RK, Kelly FJ. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr Res 1994; 36:487-493
22. Pratico D, Basili S, Vieri M, et al. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2α-III, an index of oxidant stress. Am J Respir Crit Care Med 1998; 158:1709-1714
23. Montuschi P, Corradi M, Ciabattoni G, et al. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999; 160:216-220
24. Montuschi P, Collins JV, Ciabattoni G, et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000; 162:1175-1177
25. Carpenter CT, Price PV, Christman BW. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 1998; 114:1653-1659
26. Morrison DL, Launois SH, Isono S. Pharingeal narrowing and closing pressure in patients with obstructive sleep apnea. Am Rev Respir Dis 1993; 148:606-611
27. Wynne JW. Obstruction of the nose and breathing during sleep. Chest 1982; 82:657-658
28. Reimund E. The free radical theory of sleep. Med Hypotheses 1994; 43:231-233
29. Wali SO, Bahammam AS, Massaeli H, et al. Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep 1999; 2:290-295
30. Khalid MA, Ashraf M. Direct detection of endogenous hydroxyl radical production in cultured adult cardiomyocyte during anoxia and reoxygenation: is the hydroxyl radical really the most damaging radical species? Circ Res 1993; 72:725-736
31. Kutryk MJB, Pierce GN. Effects of low density lipoprotein on calcium movements in cultured vascular smooth muscle cells. Coron Artery Dis 1991; 2:1093-1101
32. Singal PK, Kapur N, Dhilon KS, et al. Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol 1982; 60:1390-1397
33. Kresiun VI, Rozhkovskji JV. Disruption of the structural organization of brain mitochondrial membranes during deprivation of the paradoxical sleep phase and correction for it using lithonite. Ukr Biokhim Zh 1991; 63:59-65
34. Ip MSM, Lam B, Chan LY, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000; 162:2166-2171
35. Zakkar M, Sekosan M, Wenig B, et al. Decrease in immunoreactive neutral endopeptidase in uvula mucosa epithelium of patients with obstructive sleep apnea. Ann Otol Rhinol Laryngol 1997; 106:474-477
36. Barcelo A, Miralles C, Barbe F, et al. Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 2000; 16:644-647
37. He J, Kryger MH, Zorick FJ, et al. Mortality and apnea index in obstructive sleep apnea (experience in 385 male patients). Chest 1988; 94:9-14